|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1993-11-10
|
|
pubmed:abstractText |
Posttransplantation lymphoproliferative disorders after solid organ transplantation are a serious complication occurring in 1-10% of patients. Different therapies have been used, but the optimal treatment is unknown. There is relatively little information in the literature on the experience with cytotoxic chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
72
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
2782-5
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8402504-Adult,
pubmed-meshheading:8402504-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8402504-Cyclophosphamide,
pubmed-meshheading:8402504-Doxorubicin,
pubmed-meshheading:8402504-Humans,
pubmed-meshheading:8402504-Immunophenotyping,
pubmed-meshheading:8402504-Lymphoma, B-Cell,
pubmed-meshheading:8402504-Lymphoma, Large-Cell, Immunoblastic,
pubmed-meshheading:8402504-Lymphoma, Non-Hodgkin,
pubmed-meshheading:8402504-Lymphoproliferative Disorders,
pubmed-meshheading:8402504-Male,
pubmed-meshheading:8402504-Middle Aged,
pubmed-meshheading:8402504-Organ Transplantation,
pubmed-meshheading:8402504-Prednisolone,
pubmed-meshheading:8402504-Vincristine
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy.
|
|
pubmed:affiliation |
Department of Medicine, Columbia-Presbyterian Medical Center, New York, New York 10032.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
